On the origin of urinary fibrin-fibrinogen-related antigen in glomerulonephritis.
A model of antiglomerular basement membrane nephritis in the rat was used to elucidate the origin of urinary fibrin-fibrinogen-related antigen (FRA). The intrarenal distribution and excretion of 125I-rat fibrinogen was examined to determine whether there was increased filtration of bibrinogen or fibrin degradation products (FDP) or lysis of intraglomerular fibrin. 125I-protein appeared in the urine immediately after injection of 125I-fibrinogen and fell in parallel with the fall in plasma 125I-fibrinogen. Renal retention of 125I-fibrin averaged less than 0.2 percent of the administered dose of 125I-fibrinogen. The infusion of epsilon aminocaproic acid (EACA) had no significant effect on either FRA excretion or 125I-protein excretion. Plasma FDP levels and the elution patteren of 125I-protein from the urine were not significantly changed by EACA infusion. These observations support the view that ruinary FRA excretion in glomerulonephritis is derived predominantly from increased filtration of plasma fibrinogen rather than from breakdown of intraglomerular fibrin.
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D000906:Antibodies / Q000008:administration & dosage; D000941:Antigens / Q000652:urine*; D001485:Basement Membrane / Q000276:immunology; D005260:Female; D005337:Fibrin / Q000276:immunology*; D005338:Fibrin Fibrinogen Degradation Products / Q000276:immunology*; D005340:Fibrinogen / Q000276:immunology*; D005921:Glomerulonephritis / Q000139:chemically induced / Q000652:urine*; D006801:Humans; D007263:Infusions, Parenteral; D007444:Inulin; D007677:Kidney Function Tests; D011507:Proteinuria / Q000150:complications; D051381:Rats; D012965:Sodium Chloride / Q000008:administration & dosage
D000614:Aminocaproates; D000906:Antibodies; D000941:Antigens; D005338:Fibrin Fibrinogen Degradation Products; D012965:Sodium Chloride; D005337:Fibrin; D005340:Fibrinogen; D007444:Inulin